Aloradine

Unassigned

New Medicines

Social phobia (also known as social anxiety disorder)

Information

New molecular entity
VistaGen Therapeutics
VistaGen Therapeutics

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

A neuroactive steroid which targets chemosensory receptors in the nose (and is directly connected to the hypothalamus), which then inhibit nerve circuits involved in the behavioral and physiological effects of anxiety.[3]
Social anxiety disorder is one of the most common anxiety disorders. Estimates of lifetime prevalence vary but have been as high as 12% [4].
Social phobia (also known as social anxiety disorder)
Intranasal